KFS
AMLX icon

Kelly Financial Services’s Amylyx Pharmaceuticals AMLX Stock Holding History

Kelly Financial Services’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33
Closed -$63 – 146
2024
Q2 		$63 Hold
33
– – ﹤0.01% 764
2024
Q1 		$94 Hold
33
– – ﹤0.01% 766
2023
Q4 		$486 Hold
33
– – ﹤0.01% 707
2023
Q3 		$604 Hold
33
– – ﹤0.01% 669
2023
Q2 		$712 Hold
33
– – ﹤0.01% 630
2023
Q1 		$968 Hold
33
– – ﹤0.01% 597
2022
Q4 		$1.22K Hold
33
– – ﹤0.01% 553
2022
Q3 		$929 Buy
+33
New +$823 ﹤0.01% 575

Other funds holding AMLX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Kelly Financial Services's AMLX Position: Q3 2024 in Review

Kelly Financial Services sold out of Amylyx Pharmaceuticals (AMLX) in Q3 2024, closing a stake of 33 shares — an estimated $63 sold.

Kelly Financial Services first reported a position in AMLX in Q3 2022 and held it in 8 quarters. The position peaked at $1.22K in Q4 2022. 110 funds tracked by Wall St. Rank hold AMLX as of Q3 2024.

  • Kelly Financial Services reported no remaining Amylyx Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 33 Amylyx Pharmaceuticals shares in Q3 2024, an estimated $63.
  • Kelly Financial Services first reported a position in Amylyx Pharmaceuticals in Q3 2022 and held it in 8 quarters.
  • Kelly Financial Services's Amylyx Pharmaceuticals position peaked at $1.22K in Q4 2022.
  • 110 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.